James P. Whipple

Statistics

Publications

Citations

571

H-Index

Active since

1995

Affiliations

AstraZeneca (United States)(Current)

James P. Whipple is an author at AstraZeneca (United States) specializing in medicine, perioperative venous thromboembolism prophylaxis, and knee arthroplasty.

Publications per year

1995–2002

Publications

Ximelagatran versus Warfarin for the Prevention of Venous Thromboembolism after Total Knee Arthroplasty

Charles W. Francis, Bruce L. Davidson, Scott D. Berkowitz et al. · Annals of Internal Medicine · 2002 · 210 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +15

Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety

David A. Johnson, Stanley B. Benjamin, Nimish Vakil et al. · The American Journal of Gastroenterology · 2001 · 159 citations

Medicine, Clinical Sciences, Pharmacotherapy +12

Efficacy of Omeprazole for the Treatment of Symptomatic Acid Reflux Disease Without Esophagitis

Joel E. Richter, David A. Peura, Stanley B. Benjamin et al. · Archives of Internal Medicine · 2000 · 127 citations

Medicine, Clinical Sciences, Pharmacotherapy +13

Ximelagatran versus Warfarin for the Prevention of Venous Thromboembolism after Total Knee Arthroplasty

Charles W. Francis, Bruce L. Davidson, Scott D. Berkowitz et al. · Annals of Internal Medicine · 2002 · 53 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +15

Lisinopril Versus Placebo in the Treatment of Heart Failure: The Lisinopril Heart Failure Study Group

Barry M. Beller, Thomas M. Bulle, Robert C. Bourge et al. · The Journal of Clinical Pharmacology · 1995 · 22 citations

Medicine, Cardiology, Pharmacology +12

1–5 of 5